BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, April 7, 2026
Home » Authors » Anette Breindl

Articles by Anette Breindl

CAR T cells can convert suppressive to activating signals

Feb. 1, 2018
By Anette Breindl
Scientists have engineered chimeric antigen receptor (CAR) T cells to respond to TGF-beta as a stimulant rather than an immunosuppressant.
Read More

Scientists expect brain insights from first cloned monkeys

Jan. 29, 2018
By Anette Breindl

Insights, drug candidates for K-Ras-driven cancers

Jan. 29, 2018
By Anette Breindl
Separate research teams offered insight this week into how Ras-driven pancreatic cancers develop, and reported that a small molecule targeting mutated K-Ras led to tumor regression in patient-derived xenograft mouse models of K-Ras-driven cancers.
Read More

Bench Press: BioWorld looks at translational medicine

Jan. 29, 2018
By Anette Breindl
Kinase inhibitors are collectively one of the most successful drug classes, but they are challenging to develop in part because their activity usually depends on their overall effect on multiple different kinases.
Read More

Scientists expect brain insights from cloned monkeys

Jan. 25, 2018
By Anette Breindl

Scientists have the first primates born from embryos created via somatic cell nuclear transfer (SCNT), more commonly known as cloning, described in Cell.


Read More

Using one skilled immune manipulator to evoke immunity to another is TB vaccine strategy

Jan. 24, 2018
By Anette Breindl
According to the World Health Organization's (WHO's) Global tuberculosis report 2017, "TB is the ninth leading cause of death worldwide and the leading cause from a single infectious agent, ranking above HIV/AIDS. In 2016, there were an estimated 1.3 million TB deaths among HIV-negative people . . . and an additional 374,000 deaths among HIV-positive people. An estimated 10.4 million people fell ill with TB in 2016."
Read More

Using one skilled immune manipulator to evoke immunity to another is TB vaccine strategy

Jan. 23, 2018
By Anette Breindl

SEEK, and ye shall find multiple types of cancer

Jan. 22, 2018
By Anette Breindl

SEEK, and ye shall find multiple types of cancer

Jan. 22, 2018
By Anette Breindl
By looking for a combination of DNA and protein biomarkers, a single experimental blood test could detect eight different cancers, and identify the anatomical location of the majority of tumors it detected.
Read More

Using one skilled immune manipulator to evoke immunity to another is TB vaccine strategy

Jan. 18, 2018
By Anette Breindl
According to the World Health Organization's (WHO's) Global tuberculosis report 2017, "TB is the ninth leading cause of death worldwide and the leading cause from a single infectious agent, ranking above HIV/AIDS. In 2016, there were an estimated 1.3 million TB deaths among HIV-negative people . . . and an additional 374,000 deaths among HIV-positive people. An estimated 10.4 million people fell ill with TB in 2016."
Read More
Previous 1 2 … 135 136 137 138 139 140 141 142 143 … 401 402 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 6, 2026.
  • Hengrui discovers new Nav1.8 blockers

    BioWorld Science
    Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 31, 2026
  • Cancer and blood cells

    Hematopoietic stem cell research points to leukemia’s early roots

    BioWorld Science
    Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
  • 3D illustration of antibodies

    Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis

    BioWorld Science
    Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing